Select Medical's Concentra Launches IPO for 22.5M Shares on NYSE
Select Medical's Concentra Launches IPO for 22.5M Shares on NYSE
Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM) today announced that Concentra Group Holdings Parent, Inc. ("Concentra"), a wholly owned subsidiary of Select Medical, has launched a roadshow for the initial public offering ("IPO") of 22,500,000 shares of its common stock. Concentra expects to grant the underwriters a 30-day option to purchase up to an additional 3,375,000 shares of its common stock to cover over-allotments, if any. The IPO price is currently expected to be between $23.00 and $26.00 per share. Concentra has been approved to list its common stock on the New York Stock Exchange under the symbol "CON." The IPO is subject to market and other conditions, and there can be no assurance as to whether or when the IPO may be completed, or as to the actual size or terms of the IPO.
Select Medical Holdings Corporation（“Select Medical”）（紐交所：SEM）今天宣佈，全資子公司Concentra Group Holdings Parent，Inc.（“Concentra”）爲其普通股初始公開發行（“IPO”）推出了一項路演活動，發行2250萬股。如果有任何超額配售，Concentra期望授權承銷商在期權期內購買多達337.5萬股普通股。IPO股價目前預計在23.00美元至26.00美元之間。Concentra已獲批將其普通股在紐約證券交易所上市，股票代碼爲“CON”。IPO取決於市場和其他情況，不能保證IPO是否會完成或何時完成，以及IPO的實際規模或條件。
After the completion of the IPO, Select Medical will own 104,093,503 shares of Concentra's common stock, representing 82.23% of the total outstanding shares of Concentra's common stock (or 80.09% if the underwriters exercise in full their over-allotment option).
IPO完成後，Select Medical將擁有Concentra普通股的104,093,503股，佔Concentra普通股總流通股的82.23％（如果承銷商全部行使超額配售選擇權，則爲80.09％）。